The association between funding by commercial interests and study outcome in randomized controlled drug trials.
about
Effectiveness of second generation antipsychotics: a systematic review of randomized trialsFactors associated with findings of published trials of drug-drug comparisons: why some statins appear more efficacious than othersIndustry sponsorship and research outcomeRisperidone alone or in combination for acute maniaAssociation of industry funding with the outcome and quality of randomized controlled trials of drug therapy for rheumatoid arthritisRelationship between conflicts of interest and research resultsPublication bias and the pharmaceutical industry: the case of lamotrigine in bipolar disorderPharmaceutical industry sponsorship and research outcome and quality: systematic reviewSource of funding and results of studies of health effects of mobile phone use: systematic review of experimental studiesResearch ethics committees: agents of research policy?Do randomized controlled trials discuss healthcare costs?SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trialsHow evidence-based medicine is failing due to biased trials and selective publication.The tobacco industry's role in the 16 Cities Study of secondhand tobacco smoke: do the data support the stated conclusions?The availability of references and the sponsorship of original research cited in pharmaceutical advertisements.Relation of study quality, concordance, take home message, funding, and impact in studies of influenza vaccines: systematic reviewEffectiveness of anticholinergic drugs compared with placebo in the treatment of overactive bladder: systematic review.Value-based medicine: evidence-based medicine and beyond.Comparison of methadone and buprenorphine for opiate detoxification (LEEDS trial): a randomised controlled trial.Relationship of atypical antipsychotics with development of diabetes mellitus.Meta-analysis comparing denosumab and zoledronic acid for treatment of bone metastases in patients with advanced solid tumours.Conflict of Interest Disclosure Policies and Practices in Peer-reviewed Biomedical Journals.The relationship between the outcome of studies of autologous chondrocyte implantation and the presence of commercial funding.Evolution of the randomized controlled trial in oncology over three decades.Source of funding and results of studies of health effects of mobile phone use: systematic review of experimental studies.Funding source and the quality of reports of chronic wounds trials: 2004 to 2011.Economic analyses of venous thromboembolism prevention strategies in hospitalized patients: a systematic review.The financing of drug trials by pharmaceutical companies and its consequences. Part 1: a qualitative, systematic review of the literature on possible influences on the findings, protocols, and quality of drug trials.The quality of reports of randomized trials in multiple sclerosis: a review.Reporting of sources of funding in systematic reviews in periodontology and implant dentistry.Associations with publication and assessing publication bias in dementia diagnostic test accuracy studies.Financial ties of principal investigators and randomized controlled trial outcomes: cross sectional study.A new method for scoring financial conflicts of interest.Characteristics of funding of clinical trials: cross-sectional survey and proposed guidance.Point/Counterpoint. Increasing dependence on industry-funded research creates higher risk of biased reporting in medical physics.Financial conflicts of interest and their association with outcome and quality of fibromyalgia drug therapy randomized controlled trials.Are there guidelines for reporting clinical research findings in oral lectures and seminars in dental meetings?AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both.Assessment of the FDA backgrounder on platinum in silicone breast implants: implications for public health policy.Publication bias in abstracts presented to the annual meeting of the American Academy of Orthopaedic Surgeons.
P2860
Q21260262-4F37B1E1-4647-4D1E-A856-BE0095474AF7Q21563421-F6116711-8A8E-4AAE-AC30-128DEBFA8CACQ24202591-E90789BF-1324-41BB-97E4-737B877C380BQ24244719-C9F366DB-5337-4F6D-8493-B3B2AD73335DQ24289540-373B520E-28D7-48D4-91FE-CB526B0BD995Q24550578-E2E32A75-E056-4F86-B5B4-24FC039D2187Q24643545-C7AE3F4A-21B9-4BE5-8C46-98DC4DE36C43Q24673248-F70026D3-7687-41C3-BB9B-949889A6F977Q24675550-6573F12C-9012-4E3D-923C-A3BDAF0E3A1AQ24815381-547D3DBE-907C-4FAE-B22F-34530990D1FDQ28475247-1940F2A1-61F0-4DF1-A0F0-BA35FA2C9BB8Q28710019-DF527DA3-F3F1-4AF1-A951-E6F8E5232F6EQ30362457-6D48F55A-8086-4F1B-A801-6C1DECCA9FBEQ31087699-5997626D-16E4-4FBC-9B10-71A0494E3BEFQ33211922-F6AF1123-A5A3-46E9-A25F-0EE08E047871Q33408691-2AC882EB-87AF-4208-8878-A069F8CF0664Q34950386-15C63CDB-99E7-4C29-98B9-00B70973B877Q35563038-88AFD903-B620-400A-9D52-D2D82AFF8925Q35572242-55052B6B-49E9-4B36-945D-E4445671989FQ35591014-10491082-208B-4738-B861-B973DC2BEBBAQ36080739-8C314792-4AAC-4528-B0F2-915A830B6868Q36653848-23544659-87BE-46EF-8B7A-D2D7801F82ADQ36886692-52F8E831-45F7-4D1C-8888-6E0E804D441DQ37117089-9F5742EA-CB59-439A-BED2-62429FE1CDB6Q37278081-133BE399-A960-4A83-9E8D-3B158E409738Q37497269-0293F802-BA3D-4D15-9A41-0D769743C2E7Q37661478-08C6F5C3-BCF1-400A-B2B4-321F04E04248Q37751910-7AA8D727-898F-49B5-BF02-1CE72BB3AAC1Q38001975-C9E5F8BA-2388-42E1-BA80-2694907060A6Q38185927-37ED1CC8-94CE-46F4-8940-FCFE56DDC82BQ41206687-37CC2543-3611-41EC-A28F-1E9B0E056B7DQ41742515-FC0BCD23-1170-446B-9612-AD058B4F4C63Q42099220-85CE529D-2809-497C-BDCD-56CC89A9CBD0Q42376739-4503782E-51F7-4217-99B8-DF676F3FF1D6Q46120369-ED6D79A7-2813-45BF-9DC6-B7025E8AACE5Q46354967-520388B4-7E3C-433A-B302-9985DFDA2070Q46477651-53D2B6EC-F809-41AF-86A6-2542AD16B768Q47684085-94B0F5C1-6FFA-4B26-8B52-98A7FDB0813DQ47846014-53636BBB-F810-44F5-9664-5A6CA053949BQ50802677-F5733FA6-B9A2-4DDF-8039-EB380698560E
P2860
The association between funding by commercial interests and study outcome in randomized controlled drug trials.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
2001年论文
@zh
2001年论文
@zh-cn
name
The association between fundin ...... omized controlled drug trials.
@en
type
label
The association between fundin ...... omized controlled drug trials.
@en
prefLabel
The association between fundin ...... omized controlled drug trials.
@en
P2093
P2860
P356
P1433
P1476
The association between fundin ...... omized controlled drug trials.
@en
P2093
P2860
P304
P356
10.1093/FAMPRA/18.6.565
P407
P577
2001-12-01T00:00:00Z